Product image of Minorga (Minoxidil) supplied by GNH India

Minorga

Active Ingredient:
Minoxidil
Origin:
EU

Minorga (Minoxidil)

Minoxidil, the active ingredient in Minorga, is a potassium channel opener presented as a topical formulation for skin application. It treats androgenetic alopecia and other forms of hair loss in adults. The product is manufactured according to EU standards and is intended for external use on the scalp.

GNH India supplies Minorga as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality assurance protocols and provides regulatory support for cross‑border distribution.

Manufacturer / TM Owner

Laboratoires Bailleul S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Minorga (minoxidil) is used to address conditions related to hair loss by promoting follicular growth.
  • Androgenetic alopecia (male pattern): helps regrow hair on the vertex and frontal scalp.
  • Androgenetic alopecia (female pattern): supports increased hair density on thinning areas.
  • Other non‑scarring alopecia: may improve hair growth in certain diffuse hair loss conditions.
  • Telogen effluvium: can be used off‑label to accelerate regrowth after shedding episodes.

How It Works

  • Minoxidil acts as a potassium channel opener that binds to ATP‑sensitive potassium channels in dermal papilla cells of hair follicles. Opening these channels hyperpolarizes cell membranes, enhancing blood flow and prolonging the anagen (growth) phase, which stimulates follicular proliferation and increases hair shaft production. The increased vascularization supplies oxygen and nutrients to the follicle, while the prolonged growth phase reduces the proportion of follicles in the catagen and telogen stages, contributing to visible hair regrowth.

Side Effects

Minorga may cause a range of skin‑related reactions when applied to the scalp.

Common Side Effects

  • Scalp irritation or itching
  • Dryness or flaking of the treated area
  • Redness or mild erythema
  • Unwanted facial or body hair growth
  • Temporary shedding of existing hair
  • Tingling sensation at the application site

Serious or Rare Side Effects

  • Severe allergic reaction (rash, swelling, difficulty breathing)
  • Chest pain or palpitations
  • Rapid heartbeat (tachycardia)
  • Dizziness or light‑headedness
  • Swelling of hands, feet, or face
  • Unexplained weight gain or edema

Precautions & Warnings

  • Before using Minorga, consider the following safety measures.
  • Assess scalp condition: ensure no active dermatitis or infection before application.
  • Avoid use on broken or inflamed skin: apply only to intact scalp.
  • Do not apply to eyes, mucous membranes, or other non‑scalp areas.
  • Discontinue if severe irritation occurs: seek medical advice if symptoms persist.
  • Pregnancy and breastfeeding: safety not established; consult a healthcare professional.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Minorga can interact with other medications or topical agents; monitor as indicated.

Major Interactions (Avoid)

  • Systemic antihypertensive therapy: may potentiate blood‑pressure lowering effects.
  • Oral minoxidil: combined use can lead to excessive hypotension.
  • Other topical vasodilators or irritants: may increase skin irritation.

Moderate Interactions (Monitor Closely)

  • Hair dye or chemical treatments: may affect drug absorption.
  • Scalp corticosteroids: monitor for additive irritation or altered efficacy.

Frequently Asked Questions

Minorga contains minoxidil, a topical agent approved for the treatment of androgenetic alopecia in both men and women. It works by stimulating hair follicles to promote regrowth and increase hair density on the scalp.

Minoxidil opens ATP‑sensitive potassium channels in dermal papilla cells, leading to vasodilation, improved blood flow, and prolonged anagen (growth) phase of hair follicles. This environment supports follicular proliferation and results in visible hair regrowth.

The appropriate dose of Minorga is determined by a qualified prescriber based on the patient’s condition, age, and response. The prescribing professional will provide specific instructions on how much product to apply and how often.

Safety of topical minoxidil during pregnancy or lactation has not been established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using Minorga.

To request Minorga, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Minorga’s active ingredient, minoxidil, is a well‑studied potassium channel opener and is the only topical medication approved for both male and female pattern hair loss. Other classes, such as oral finasteride, act systemically on hormonal pathways, whereas Minorga works locally on the scalp without systemic hormonal effects.

Store Minorga at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Minorga is applied directly to a clean, dry scalp. The prescriber will indicate the amount to use (typically a measured drop or pump) and the frequency, usually twice daily. The solution should be spread evenly over the affected area and allowed to dry before styling or using other hair products.

Serious but rare risks include severe allergic reactions such as rash, swelling, or difficulty breathing, and cardiovascular effects like chest pain, rapid heartbeat, or dizziness. If any of these symptoms occur, discontinue use immediately and seek medical attention.

Minorga should not be used by individuals with known hypersensitivity to minoxidil or any component of the formulation, by those with active scalp infections or dermatitis, and by patients on systemic antihypertensive therapy without medical supervision. Pregnant or breastfeeding women should consult a healthcare professional before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Minoxidil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT